Concepedia

Himanshu Savardekar

HS

Statistics

Publications

6

Citations

156

H-Index

6

Active since

2017

Affiliations

The Ohio State University(Current)

The Ohio State University Wexner Medical Center

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Himanshu Savardekar is an author at The Ohio State University specializing in immunology, oncology, and tumor immunology.

ORCID

Publications per year

2017–2025

6

Publications

6

PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis

Lindsay Webb, Stephanie A. Amici, Kyle Jablonski et al. · The Journal of Immunology · 2017 · 67 citations · Full text

, , +15

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma

Steven Sun, Brooke Benner, Himanshu Savardekar et al. · Frontiers in Immunology · 2021 · 37 citations · Full text

, , +17

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer

Robert Wesolowski, Andrew Stiff, Dionisia Quiroga et al. · BMC Cancer · 2020 · 16 citations · Full text

, , +17

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy

Steven Sun, Colin D. Angell, Himanshu Savardekar et al. · Cancer Immunology Immunotherapy · 2023 · 14 citations · Full text

, , +17

Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells

Dwight H. Owen, Brooke Benner, Carly Pilcher et al. · Clinical Lung Cancer · 2020 · 12 citations · Full text

, , +17

1–5 of 6